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Introducction 
PAX9 is a transcription factor expressed in the tooth mesenchyme during tooth 
morphogenesis. In Pax9-null mice, tooth development is arrested at the bud stage and cleft 
palate and other skeletal abnormalities in the head and limbs are observed. In humans, 
heterozygous mutations in PAX9 have been associated with non-syndromic tooth agenesis, 
affecting predominantly molars. The purpose of this study is to identify tooth agenesis 
causing mutations in two unrelated patients with oligodontia and to study the characteristic 
of the mutated proteins. 
Matherial and Methods 
Pedigrees of the family were made by clinical examinations and interviews, and the 
diagnosis was verified by panoramic radiographs. Genomic DNA was extracted from saliva, 
and MSX1, PAX9, AXIN2, and WNT10A were selected for sequence analysis. Sequencing 
results were compared with online databases, and the putative functional consequences of 
all identified mutations were analyzed in silico with PolyPhen-2 and MutationTaster. Next, 
full coding sequence of mutant PAX9 expression vectors obtained by in vitro site-directed 
mutagenesis was clone in-frame into pCMV-3Tag-2A, and then transfected in COS7 cells to 
analyse the expression and the nuclear localization of the mutant proteins 48 hours after 
transfection. Luciferase reporter assay was performed to verify the transactivation of the 
BMP4 promoter. This study was approved by the Ethical Committee of Tokushima 
University Hospital (H23-8). 
Results 
Novel mutations in the paired domain of PAX9, a three-nucleotide deletion and a missense 
mutation, were identified. The individual with the c.73-75 delATC mutation was missing all 
maxillary molars and mandibular second and third molars. The individual with the c.C146T 
mutation was missing the mandibular central incisors, maxillary second premolars, and 
first molars, along with all second and third molars. In silico analyses predicted that both 
mutations are disease-causing. 
Fluorescent immunocytochemistry showed nuclear localization of wild-type and mutant 
PAX9 proteins. Western blot analysis revealed lower protein expression in cell lysates of 
mutated PAX9-transfected COS7 cells compared with the wild-type PAX9-transfected cells. 
In addition, no transcriptional activities of the target BMP4 promoter were observed in mutant 
PAX9. 
Discussion and Conclusion 
Novel c.73-75delATC and c.C146T mutations in PAX9 were identified in two unrelated 
patients with non-syndromic tooth agenesis. The patients showed agenesis affecting 
preferentially molars, as described in previous PAX9 mutation reports. Both mutations 
affected amino acids that are highly conserved among different species and are critical for 
DNA binding. Although nuclear localization of the mutant PAX9 proteins were not affected, 
the expression of both proteins were reduced. Our in vitro study supported the prediction of 
the in silico analysis, as a disease-causing mutation. On the basis of our results, we 
suggested that the two identified PAX9 mutations affect DNA binding and BMP4 promoter 
transactivation, supporting the mechanism of functional habloinsufficiency as the 
underlying cause of tooth agenesis. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
